Fred Immermann

919 total citations
16 papers, 756 citations indexed

About

Fred Immermann is a scholar working on Rheumatology, Oncology and Epidemiology. According to data from OpenAlex, Fred Immermann has authored 16 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Fred Immermann's work include Cancer Genomics and Diagnostics (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Alzheimer's disease research and treatments (2 papers). Fred Immermann is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Alzheimer's disease research and treatments (2 papers). Fred Immermann collaborates with scholars based in United States, Canada and Sweden. Fred Immermann's co-authors include R. I. E. Newell, Richard K. Koehn, Andrew J. Dorner, Michael E. Burczynski, Natalie C. Twine, Andrew Strahs, Walter Spinelli, Lori Casciotti, Ron Peterson and Monette Cotreau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

Fred Immermann

15 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Immermann United States 10 304 188 140 105 99 16 756
Dale E. Greenwalt United States 16 462 1.5× 100 0.5× 84 0.6× 56 0.5× 152 1.5× 43 1.0k
F. Ferrara Italy 19 598 2.0× 98 0.5× 215 1.5× 50 0.5× 122 1.2× 84 1.3k
Mohammad Alavi United States 17 425 1.4× 109 0.6× 189 1.4× 45 0.4× 106 1.1× 29 1.0k
Laura Richardson United States 16 270 0.9× 88 0.5× 391 2.8× 82 0.8× 170 1.7× 25 987
Glenn Stone Australia 16 530 1.7× 172 0.9× 206 1.5× 28 0.3× 174 1.8× 32 1.2k
Nicholas Lewin‐Koh United States 17 343 1.1× 86 0.5× 234 1.7× 117 1.1× 87 0.9× 29 1.2k
Haiyan Pan China 18 154 0.5× 83 0.4× 140 1.0× 264 2.5× 236 2.4× 46 1.1k
Jing‐Woei Li Hong Kong 21 651 2.1× 194 1.0× 284 2.0× 53 0.5× 137 1.4× 39 1.5k
Ann Nomoto United States 13 274 0.9× 109 0.6× 46 0.3× 46 0.4× 104 1.1× 14 681
Simon Travers France 21 514 1.7× 157 0.8× 124 0.9× 39 0.4× 91 0.9× 49 1.2k

Countries citing papers authored by Fred Immermann

Since Specialization
Citations

This map shows the geographic impact of Fred Immermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Immermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Immermann more than expected).

Fields of papers citing papers by Fred Immermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Immermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Immermann. The network helps show where Fred Immermann may publish in the future.

Co-authorship network of co-authors of Fred Immermann

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Immermann. A scholar is included among the top collaborators of Fred Immermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Immermann. Fred Immermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tan, Charles Y., Fred Immermann, Shite Sebastian, et al.. (2018). Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides. mSphere. 3(4). 24 indexed citations
2.
Merrill, Joan T., Fred Immermann, Maryann Z. Whitley, et al.. (2017). The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis & Rheumatology. 69(6). 1257–1266. 34 indexed citations
3.
Hill, Andrew A., Fred Immermann, Padmalatha S. Reddy, et al.. (2013). FRI0003 Determination of interferon (IFN) signatures for sle patients may be critical for optimal treatment selection but depends on the genes chosen: report from the bold (biomarkers of lupus disease) study. Annals of the Rheumatic Diseases. 72. A369–A370. 2 indexed citations
4.
5.
6.
Seyhan, Attila A., Margot O’Toole, Fred Immermann, et al.. (2012). OP0063 Impact of baseline interferon pathway activation on widespread gene expression changes with disease flare in lupus patients: Interim report from the bold (biomarkers of lupus disease) study. Annals of the Rheumatic Diseases. 71. 74–74. 1 indexed citations
7.
Soares, Holly, William Z. Potter, Fred Immermann, et al.. (2011). P2‐070: Changes in plasma based biomarkers in Alzheimer's disease, mild cognitively impaired and aged matched normal controls from the ADNI cohort. Alzheimer s & Dementia. 7(4S_Part_10). 1 indexed citations
8.
Sellar, Grant C., John Alvarez, Frank Loganzo, et al.. (2008). Opportunities Posed by Novel Patient Selection Biomarker Approaches in Oncology Drug Development: Going Beyond the Cytotoxics. Biomarkers in Medicine. 2(2). 147–153.
9.
Burczynski, Michael E., Ron Peterson, Natalie C. Twine, et al.. (2006). Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells. Journal of Molecular Diagnostics. 8(1). 51–61. 191 indexed citations
10.
Burczynski, Michael E., Natalie C. Twine, Gary Dukart, et al.. (2006). Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma. The Journal of Urology. 175(3). 892–893. 12 indexed citations
11.
Boni, Joseph, Cathie Leister, Virginia Fitzpatrick, et al.. (2005). Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer. Clinical Pharmacology & Therapeutics. 77(1). 76–89. 68 indexed citations
12.
Burczynski, Michael E., Natalie C. Twine, Gary Dukart, et al.. (2005). Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma. Clinical Cancer Research. 11(3). 1181–1189. 100 indexed citations
13.
Dunman, Paul M., Fionnuala McAleese, Fred Immermann, et al.. (2004). Uses of Staphylococcus aureus GeneChips in Genotyping and Genetic Composition Analysis. Journal of Clinical Microbiology. 42(9). 4275–4283. 38 indexed citations
14.
Wrenn, Simeon M., John S. Parks, Fred Immermann, & L L Rudel. (1995). ACAT inhibitors CL 283,546 and CL 283,796 reduce LDL cholesterol without affecting cholesterol absorption in African green monkeys.. Journal of Lipid Research. 36(6). 1199–1210. 22 indexed citations
15.
Jacobus, N V, et al.. (1993). Susceptibility of Anaerobes in Phase 3 Clinical Studies of Piperacillin/Tazobactam. Clinical Infectious Diseases. 16(Supplement_4). S344–S348. 9 indexed citations
16.
Koehn, Richard K., R. I. E. Newell, & Fred Immermann. (1980). Maintenance of an aminopeptidase allele frequency cline by natural selection.. Proceedings of the National Academy of Sciences. 77(9). 5385–5389. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale E. Greenwalt Breakdown of academic impact, for papers by F. Ferrara Breakdown of academic impact, for papers by Mohammad Alavi Breakdown of academic impact, for papers by Laura Richardson Breakdown of academic impact, for papers by Glenn Stone Breakdown of academic impact, for papers by Nicholas Lewin‐Koh Breakdown of academic impact, for papers by Haiyan Pan Breakdown of academic impact, for papers by Jing‐Woei Li Breakdown of academic impact, for papers by Ann Nomoto Breakdown of academic impact, for papers by Simon Travers
Rankless by CCL
2026